Compositions for reprogramming somatic cells

Details Compositions for reprogramming somatic cells Compositions for reprogramming somatic cells

2010-02-09

2011-12-06

Noble, Marcia S (Department: 1632)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C435S354000, C435S366000

Reexamination Certificate

active

08071369

ABSTRACT:
The invention provides methods for reprogramming somatic cells to generate multipotent or pluripotent cells. Such methods are useful for a variety of purposes, including treating or preventing a medical condition in an individual. The invention further provides methods for identifying an agent that reprograms somatic cells to a less differentiated state.

REFERENCES:
patent: 5824837 (1998-10-01), Chen et al.
patent: 7682828 (2010-03-01), Jaenisch et al.
patent: 7687266 (2010-03-01), Chambers et al.
patent: 2002/0168660 (2002-11-01), Chen et al.
patent: 2004/0137460 (2004-07-01), Yamanaka et al.
patent: 2006/0084172 (2006-04-01), Muller et al.
patent: 2010/0144031 (2010-06-01), Jaenisch et al.
patent: WO 99/55841 (1999-11-01), None
patent: WO 02/097090 (2002-12-01), None
Stem Cells: Scientific Progress and Future Research Directions. Department of Health and Human Services. Jun. 2001. </info/scireport/2001report>. Chapter 4: The Adult Stem Cell, pp. 23-42.
Chambers et al., “Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells,”Cell113:843-655 (2003).
Hansis et al., “Analysis of Oct.-4 expression and ploidy in individiual human blastomeres,”Molecular Human Reproduction, 7: 155-161 (2001).
Mitsui et al., “The Homeoprotein Nanog is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells,”Cell, 113: 631-642 (2003).
Mountford et al., “Dicistronic targeting constructs: Reporters and modifiers of mammalian gene expression,”Proceedings of the National Academy of Sciences, 91: 4303-4307 (1994).
Niwa et al., “Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells,”Nature Genetics, 24: 372-376 (2000).
Ramalho-Santos et al., “‘Stemness’ Transcriptional Profiling of Embryonic and Adult Stem Cells,”Science, 298: 597-800 (2002).
Tada et al., “Nuclear Reprogramming of Somatic Cells by in Vitro Hybridization with ES cells,”Current Biology, 11 1553-1558 (2001).
BLAST Alignment SEQ ID 16 (ECAT4), Apr. 28, 2011.
Final Office Action for U.S. Appl. No. 12/708,061, mailed Jul. 14, 2011.
Ben-Shushan et al., “Extinction of Oct-3/4 gene expression in embryonal carcinoma x fibroblast somatic cell hybrids is accompanied by changes in the methylation status, chromatin structure, and transcriptional activity of the Oct-3/4 upstream region,” Molecular and Cellular Biology 13(2):891-901 (1993).
Bronson et al., “Single-copy transgenic mice with chosen-site integration,” Proc. Natl. Acad. Sci. USA 93:9067-9072 (1996).
Buske et al., “Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo,” Blood 97(8):2286-2292 (2001).
Chambers et al., “Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells,” Cell 113:643-655 (2003).
Daniels et al., “Analysis of Gene Transcription in Bovine Nuclear Transfer Embryos Reconstructed with Granulosa Cell Nuclei,” Biology of Reproduction 63:1034-1040 (2000).
Gossen et al., “Transcriptional activation by tetracyclines in mammalian cells,” Science 268(5218):1766-1769 (1995).
Helgason et al., “Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro,” Blood 87(7):2740-2749 (1996).
Hochedlinger et al., “Monoclonal mice generated by nuclear transfer from mature B and T donor cells,” Nature 415:1035-1038 (2002).
Hochedlinger et al., “Nuclear transplantation, embryonic stem cells, and the potential for cell therapy,” The New England Journal of Medicine 349(3):275-286 (2003).
Jaenisch et al., “Nuclear cloning, stem cells, and genomic reprogramming,” Cloning and Stem Cells 4(4):389-396 (2002).
Kaufman et al., “Hematopoietic colony-forming cells derived from human embryonic stem cells,” PNAS 98(19) :10716-10721 (2001).
Kyba et al., “HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors,” Cell 109:29-37 (2002).
Lenardo et al., “Repression of the IgH Enhancer in Teratocarcinoma Cells Associated with a Novel Octamer Factor,” Science, New Series 243(4890):544-546 (1989).
Matsuoka et al., “Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region-derived stromal cells,” Blood 98(1):6-12 (2001).
McWhir et al., “Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background,” Nature Genetics 14:223-226 (1996).
Mitsui et al., “The homeoprotein nanog is required by maintenance of pluripotency in mouse epiblast in ES cells,” Cell 113:631-642 (2003).
Mountford et al., “Dicistronic targeting constructs: Reporters and modifiers of mammalian gene expression,” Proceedings of the National Academy of Sciences 91:4303-4307 0994).
Munsie et al., “Transgenic strategy for demonstrating nuclear reprogramming in the mouse,” Cloning Stem Cells 4(2):121-130 (2002).
Naito et al., Journal of Reproduction and Fertility 113:137-143 (1998).
Niwa et al., “Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells,” Nature Genetics 24:372-376 2000.
Peled et al., “Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4,” Science 283:845-848 (1999).
Pesce et al., “Oct-4: Gatekeeper in the beginnings of mammalian development,” Stem Cells 19:271-278 (2001).
Tada et al., “Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells,” Current Biology 11:1553-1558 (2001).
Yeom et al., “Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells,” Development 122:881-897 (1996).
Yoshimizu et al., “Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice,” Development, Growth & Differentiation 41:675-684 (1999).
Zakhartchenko et al., “Adult cloning in cattle: potential of nuclei from a permanent cell line and from primary cultures,” Molecular Reproduction and Development 54:264-272 (1999).
Zambrowicz et al., “Disruption of overlapping transcripts in the ROSA βgeo 26 gene trap strain leads to widespread expression of β-galactosidase in mouse embryos and hematopoietic cells,” Proc. Natl. Acad. Sci. USA 94:3789-3794 (1987).
Sox2. print out from Pubmed http://www.ncbi.nlm.nih.gov
uccore/127140985?ordinalp...ntrez.Sequence.Sequence—ResultsPanel.Sequence—RVDocSum p. 1-6, printed Apr. 7, 2009.
Nanog. Printout from Pubmed http://www.ncbi.nlm.nih.gov
uccore/153791181?ordinalp...netrez.Sequence.Sequence—ResultsPanel.Sequence—RVDocSum p1-6, printed Apr. 7, 2009.

Affiliated with

Also associated with

Rating

Compositions for reprogramming somatic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions for reprogramming somatic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for reprogramming somatic cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4306991